For Specialized Pharmacy and Health Care Legal Services Call (720)222-1276 • Baer Law provides services to all of the United States
Baer Law
25521 E. Smoky Hill Road
Suite #120, Aurora, CO 80016
720.222.1276

About Baer Law
John brings over twenty-five combined years of experience as a pharmacist and attorney to the Baer Law Firm LLC. John's personal goal since finishing law school was to incorporate both his experiences as a clinical pharmacist and an attorney into his own, successful law practice. After obtaining his undergraduate and his Doctorate of Pharmacy (PharmD) degrees from the University of Arizona, John relocated to Colorado. He continued to work as a clinical hospital pharmacist while attending law school and obtained his Juris Doctorate (JD) at the University of Denver College of Law.

Our Legal Services
We are uniquely positioned to understand the complex needs of our diverse clients.

Pharmacy Law
As an expert in the field, Baer Law covers a variety of Pharmaceutical Law services ranging from Federal & State Regulatory Issues to FDA Compliance and Drug Compounding.

Health Care Law
Baer Law focuses on a variety of health care law services ranging from Telemedicine / Telepharmacy and HIPAA Compliance to Professional Board Actions.
Client Testimonial
Outsourcing Facilities: Section 503B
The Drug Quality and Security Act (DQSA) can be separated into two sections: Title I addresses drug compounding and Title II relates to drug supply chain security. Section 503A of the Food, Drug and Cosmetic Act (FDCA) addresses compounding requirements, where as Section 503B defines and describes “outsourcing facilities.” Outsourcing Facilities are defined as a…
Compounding: Section 503A Changes
The regulatory landscape for pharmacy compounding has changed immensely since the passage of the Drug Quality and Security Act (DQSA) in November 2013. Historically, the Food and Drug Administration (FDA) has not strictly enforced pharmacy compounding under the FDA Modernization Act of 1997. However, the passage of the DQSA, which updated Section 503A of the…
Enhancing FDA Communications: DQSA Update
The Food and Drug Administration (FDA) was granted some new authority this week by the Department of Health and Human Services (DHHS), its parent organization. The new authority, though not unexpected or substantial, pertains to the Drug Quality and Security Act (DQSA) which was passed in late 2013 in response to the deadly New England…